NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today introduced VEVYE® Access for All, a groundbreaking initiative that underscores Harrow’s long‑standing commitment to acces…
Author: Business Wire
RetinaLogik Secures $1.1M in Funding and Health Canada Class II Approval, Advancing the Future of Eye Care
CALGARY, Alberta–(BUSINESS WIRE)–RetinaLogik Inc., a Calgary-based startup, is proud to announce it has successfully completed a $1.1 million funding round and has received Health Canada’s Class II medical device approval for its cutting-edge technol…
GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central …
GenSight Biologics annonce des communications scientifiques sur LUMEVOQ® au Congrès 2025 du NANOS
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurod…
U.S. Contact Lenses Industry Forecast to Reach $4.67 Billion by 2033 – Aging Population and Digital Eye Strain Drive Increased Contact Lens Adoption – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United States Contact Lenses Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The United States contact lenses market was valued at U…
Allergic Conjunctivitis Market Global Report and Competitive Analysis 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun Pharma, Teva – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergic Conjunctivitis Market Global Report Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The Allergic Conjunctivitis market is expected…
20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support
BOSTON–(BUSINESS WIRE)–20/20 Onsite is proud to announce its recognition with the Safety Excellence Award by Whip Around.
Alcon to Host 2025 Capital Markets Day
GENEVA–(BUSINESS WIRE)–Alcon to Host 2025 Capital Markets Day
Alcon to Host 2025 Capital Markets Day
GENEVA–(BUSINESS WIRE)–Alcon to Host 2025 Capital Markets Day
National Vision Awards $12,500 to Three Optometry Students in 10th Annual Scholarship Program
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced today the winners of its 10th annual scholarship program, awarding $12,500 in scholarships …
Sydnexis Announces FDA Acceptance of New Drug Application for SYD-101 for the Treatment of Progression of Pediatric Myopia
DEL MAR, Calif.–(BUSINESS WIRE)–Sydnexis, Inc. (www.sydnexis.com), a pre-commercial stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for SYD-101 and has assi…
Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial Officer
LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced the appointment of Carol K…
National Vision Announces Participation in UBS Global Consumer and Retail Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company is scheduled to present at the UBS Global Consumer and Retail Conference on Wednesday, March 12, 2025, at 2…
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Topcon Healthcare, Inc., RadiusXR, and Glaukos Corporation (NYSE: GKOS) announced a new collaboration and the launch of RadiusXR’s new wearable vision testing platform – Inspire®. This collaboration unites RadiusXR…
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced the execution of a five-year strategic supply and development (“SSD”) agreement for TRIESENCE® (triamcinolone acetoni…
Preservative Freedom Coalition Survey Reveals Urgent Need for Enhanced Patient-Physician Communication in Glaucoma
WALTHAM, Mass.–(BUSINESS WIRE)–The Preservative Freedom Coalition, a group of stakeholders across eye health that focuses on raising awareness of unmet needs in ocular surface disease, today announced the results of a new nationwide survey delving in…
BVI Medical Secures Strategic Capital Raise to Fuel Global Growth and Innovation
WALTHAM, Mass.–(BUSINESS WIRE)–BVI Medical, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the completion of a $1 billion strategic capital raise in partnership with TP…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that a maj…
Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it will hold a virtual Special Meeting on April 16, 2025, at which stockholders will vote on a proposal for the liquidation …